BioSpace News Archive

VectivBio Holding AG today announced they will report financial results for the full year ended December 31, 2022 and provide a business update on Wednesday, April 19, 2023 at 8:00 a.m. ET.

Creative Medical Technology Holdings, Inc. today announced positive one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported.

Beacon Biosignals today announced it has named biotechnology industry veteran Christine Vietz, Ph.D., as Chief Research and Development Officer.

INOVIO today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Geneos Therapeutics today announced that it has secured $5 million in its Series A3 round.

Freenome, a privately held biotech company, announced that the Institute for Population and Precision Health at the University of Chicago has joined as a study partner for its Vallania Study.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its first quarter 2023 financial results on Friday May 5, 2023, prior to market open.

PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023.

Caraway Therapeutics today announced that the Company will be participating in the 22nd Annual Needham Healthcare Conference, taking place April 17-20, 2023.

Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.